- Home
- OKE vs SNN Comparison
OKE vs SNN Comparison
Compare OKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OKE | SNN |
|---|---|---|
| Founded | 1906 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3B | 14.3B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | OKE | SNN |
|---|---|---|
| Price | $86.60 | $33.12 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $89.40 | $36.25 |
| AVG Volume (30 Days) | ★ 4.3M | 808.7K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.02% | 2.27% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | ★ 5.42 | N/A |
| Revenue | ★ $22,386,892,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.36 | $5.36 |
| P/E Ratio | ★ $15.73 | $64.97 |
| Revenue Growth | ★ 35.35 | N/A |
| 52 Week Low | $64.02 | $23.91 |
| 52 Week High | $103.64 | $38.79 |
Technical Indicators
Market Signals| Indicator | OKE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 40.55 |
| Support Level | $79.21 | $32.08 |
| Resistance Level | $88.35 | $33.89 |
| Average True Range (ATR) | 2.12 | 0.67 |
| MACD | -0.23 | -0.35 |
| Stochastic Oscillator | 86.25 | 17.53 |
Price Performance
Historical ComparisonAbout OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation, as well as natural gas liquids transportation and fractionation. It also operates in the refined product and crude oil segment, connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.